|
|
Volumn 64, Issue 9, 2003, Pages 1122-1129
|
|
Reducing the risk for suicide in schizophrenia and affective disorders
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMITRIPTYLINE;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
ANXIOLYTIC AGENT;
ATYPICAL ANTIPSYCHOTIC AGENT;
CARBAMAZEPINE;
CITALOPRAM;
CLOZAPINE;
DOSULEPIN;
FLUVOXAMINE;
IMIPRAMINE;
LAMOTRIGINE;
LITHIUM;
MAPROTILINE;
MIANSERIN;
MIRTAZAPINE;
MOOD STABILIZER;
NEFAZODONE;
NEUROLEPTIC AGENT;
OLANZAPINE;
PAROXETINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRAZODONE;
TRICYCLIC ANTIDEPRESSANT AGENT;
UNCLASSIFIED DRUG;
VALPROIC ACID;
VENLAFAXINE;
ALCOHOL ABUSE;
BIPOLAR DISORDER;
CAUSE OF DEATH;
CLINICAL TRIAL;
COMORBIDITY;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DRUG EFFICACY;
ELECTROCONVULSIVE THERAPY;
FEMALE;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MAJOR DEPRESSION;
MALE;
MEDICAL SOCIETY;
META ANALYSIS;
MOOD DISORDER;
MORTALITY;
ONSET AGE;
PARKINSONISM;
PHASE 3 CLINICAL TRIAL;
PREVALENCE;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
PSYCHOSIS;
PUBLICATION;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SCHIZOAFFECTIVE PSYCHOSIS;
SCHIZOPHRENIA;
SIDE EFFECT;
SINGLE BLIND PROCEDURE;
SMOKING;
SUBSTANCE ABUSE;
SUICIDAL BEHAVIOR;
SUICIDE;
SUICIDE ATTEMPT;
TREATMENT FAILURE;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 0141717211
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/JCP.v64n0920 Document Type: Conference Paper |
|
Times cited : (40)
|
|
References (0)
|